Sort
23,748 grants matching “melanoma”
MATCHMAKERS: SOLVING TCR RECOGNITION AND DESIGN VIA INTEGRATED HIGH-THROUGHPUT SCREENING, STRUCTURAL, FUNCTIONAL, AND COMPUTATIONAL APPROACHES
$336,216Kenan Christopher Garcia · Stanford University · OT2 · FY2025 · CA
Bone cancer and skeletal pain
$336,182University Of Minnesota Twin Cities · R01 · FY2001 · CA
The role of the tumor biofilm in determining tissue tropism
$336,170Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
A novel NKG2D-specific BiTE cancer immunotherapy
$336,150Charles L Sentman · Dartmouth College · R01 · FY2015 · CA
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer
$336,150Young J. Kim · Johns Hopkins University · R01 · FY2016 · CA
Design of Therapeutic Strategies Specific for Breast Cancer Initiating Cells
$336,150Germana Rappa · Nevada Cancer Institute · R01 · FY2010 · CA
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer
$336,150Young J. Kim · Johns Hopkins University · R01 · FY2013 · CA
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer
$336,150Young J. Kim · Johns Hopkins University · R01 · FY2015 · CA
A novel NKG2D-specific BiTE cancer immunotherapy
$336,150Charles L Sentman · Dartmouth College · R01 · FY2016 · CA
A novel NKG2D-specific BiTE cancer immunotherapy
$336,150Charles L Sentman · Dartmouth College · R01 · FY2017 · CA
NIAMS - Research Training in Dermatology
$336,146Richard L Edelson · Yale University · T32 · FY2007 · AR
Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
$336,136Frank J. Rauscher · Wistar Institute · R01 · FY2013 · CA
Designing Lymph Nodes for Cancer Immunotherapy
$336,129James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Microenvironment mediated drug resistance in melanoma.
$336,129Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Treatment of Melanoma with Optimzed Peptide Vaccines
$336,129Esteban Celis · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Treatment of Melanoma with Optimzed Peptide Vaccines
$336,129Esteban Celis · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
Designing Lymph Nodes for Cancer Immunotherapy
$336,129James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
Mechanisms of MEK/ERK growth arrest signaling
$336,105Jong-In Park · Medical College Of Wisconsin · R01 · FY2019 · CA
Micellar Carriers for Sparingly Soluble Pharmaceuticals
$336,012Vladimir P Torchilin · Northeastern University · R01 · FY2007 · EB
Cellular Pharmacology of Rapamycin
$336,000Burnham Institute For Medical Research · R01 · FY2005 · CA
Cellular Pharmacology of Rapamycin
$336,000Burnham Institute For Medical Research · R01 · FY2004 · CA
Cellular Pharmacology of Rapamycin
$336,000Burnham Institute For Medical Research · R01 · FY2003 · CA
ANGIOGENIC FACTORS ASSOCIATED WITH UVEAL MELANOMA
$335,984University Of Wisconsin Madison · R01 · FY2002 · EY
High-Throughput DNA-Methylation Profiling from Fixed Melanocytic Tissues
$335,977Nancy E Thomas · Univ Of North Carolina Chapel Hill · R33 · FY2011 · CA
Oncogenic Met Signaling in Urologic Malignancies
$335,956Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA